Obesity
Not recruitingEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
- Disease:Obesity
- Substances:–
Germany- Participants:18–64 years · 65+ years
- Sponsor:Metsera Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany24 clinical trials in Reinfeld, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on heart failure prevention and management of atherosclerotic cardiovascular disease. Research includes innovative combination therapies and new approaches to reducing major cardiovascular events.
Novel treatments including baxdrostat and obicetrapib are being evaluated for their effectiveness in cardiovascular risk reduction.
Comprehensive research into Type 2 Diabetes and its complications, including studies on innovative treatments and management strategies. Special focus on diabetic complications and metabolic health.
Evaluation of tirzepatide and other emerging therapies for better metabolic disease control.
Innovative approaches to treating various forms of chronic pain, including diabetic peripheral neuropathy and chronic back pain. Studies explore both traditional and alternative treatment methods.
Testing new therapeutic options including medical cannabis aerosols and novel pain medications.
Research focusing on prevention and treatment of various infections, including Cytomegalovirus (CMV) and E. coli-related diseases. Vaccine development and immunological studies are key components.
Studies include innovative mRNA vaccines and specialized treatments for various infectious conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.